World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
10520
World Ranking
3972
National Ranking
1818

Best Publications

  • Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

    John H. Sampson;Amy B Heimberger;Gary E. Archer;Kenneth D. Aldape

  • Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.

    Peter E. Fecci;Duane A. Mitchell;John F. Whitesides;Weihua Xie

  • Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

    Duane A. Mitchell;Kristen A. Batich;Michael D. Gunn;Min-Nung Huang

  • Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.

    Peter A. Humphrey;Albert J. Wong;Bert Vogelstein;Michael R. Zalutsky

  • Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function.

    Peter E. Fecci;Hidenobu Ochiai;Duane A. Mitchell;Peter M. Grossi

  • Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-α and a Mutated form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors

    John H. Sampson;Gamal Akabani;Gary E. Archer;Darell D. Bigner

  • Mutant Epidermal Growth Factor Receptor Up-Regulates Molecular Effectors of Tumor Invasion

    Anita Lal;Chad A. Glazer;Holly M. Martinson;Henry S. Friedman

  • An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme.

    John H. Sampson;Gary E. Archer;Duane A. Mitchell;Amy B. Heimberger

  • Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination

    Kristen A. Batich;Elizabeth A. Reap;Gary E. Archer;Luis Sanchez-Perez

  • Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system

    John H. Sampson;Gerald E. Archer;David M. Ashley;Herbert E. Fuchs

  • Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors.

    Amy B. Heimberger;Laura E. Crotty;Gary E. Archer;Kenneth R. Hess

  • The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target

    C J Wikstrand;C J Reist;G E Archer;M R Zalutsky

  • Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors.

    John H. Sampson;Laura E. Crotty;Samson Lee;Gary E. Archer

  • Brain Tumors in Mice Are Susceptible to Blockade of Epidermal Growth Factor Receptor (EGFR) with the Oral, Specific, EGFR-Tyrosine Kinase Inhibitor ZD1839 (Iressa)

    Amy B. Heimberger;Chris A. Learn;Gary E. Archer;Roger E. McLendon

  • Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma

    John H. Sampson;Gary E. Archer;Duane A. Mitchell;Amy B. Heimberger

  • Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme.

    Chris A. Learn;Tristan L. Hartzell;Carol J. Wikstrand;Gary E. Archer

  • Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma

    Bryan D. Choi;Chien-Tsun Kuan;Mingqing Cai;Gary E. Archer

  • EGFRvIII-Targeted Vaccination Therapy of Malignant Glioma

    Bryan D. Choi;Gary E. Archer;Duane A. Mitchell;Amy B. Heimberger

  • A Novel Inhibitor of Signal Transducers And Activators Of Transcription 3 Activation Is Efficacious Against Established Central Nervous System Melanoma and Inhibits Regulatory T Cells

    Ling Yuan Kong;Mohamed K. Abou-Ghazal;Jun Wei;Arup Chakraborty

  • Tumor-specific Anti-Epidermal Growth Factor Receptor Variant III Monoclonal Antibodies: Use of the Tyramine-Cellobiose Radioiodination Method Enhances Cellular Retention and Uptake in Tumor Xenografts

    Craig J. Reist;Gary E. Archer;Shekar N. Kurpad;Carol J. Wikstrand

Frequent Co-Authors

Darell D. Bigner
Darell D. Bigner Duke University
John H. Sampson
John H. Sampson Duke University
Henry S. Friedman
Henry S. Friedman Duke University
James E. Herndon
James E. Herndon Duke University
Roger E. McLendon
Roger E. McLendon Duke University
Allan H. Friedman
Allan H. Friedman Duke University
David A. Reardon
David A. Reardon Harvard University
Michael R. Zalutsky
Michael R. Zalutsky Duke University
Smita Nair
Smita Nair Duke University
Ira Pastan
Ira Pastan Center for Cancer Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Gary E. Archer

Recently Published Articles